Literature DB >> 19237271

Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study.

Chuck T Chen1, Zhen Liu, Melissa Ouellet, Frédéric Calon, Richard P Bazinet.   

Abstract

Analyses of brain phospholipid fatty acid profiles reveal a selective deficiency and enrichment in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), respectively. In order to account for this difference in brain fatty acid levels, we hypothesized that EPA is more rapidly beta-oxidized upon its entry into the brain. Wild-type C57BL/6 mice were perfused with either (14)C-EPA or (14)C-DHA via in situ cerebral perfusion for 40s, followed by a bicarbonate buffer to wash out the residual radiolabeled polyunsaturated fatty acid (PUFA) in the capillaries. (14)C-PUFA-perfused brains were extracted for chemical analyses of neutral lipid and phospholipid fatty acids. Based on the radioactivity in aqueous, total lipid, neutral lipid and phospholipid fractions, volume of distribution (V(D), microl/g) was calculated. The V(D) between (14)C-EPA- and (14)C-DHA-perfused samples was not statistically different for total lipid, neutral lipids or total phospholipids. However, the V(D) of (14)C-EPA in the aqueous fraction was 2.5 times higher than that of (14)C-DHA (p=0.025), suggesting a more extensive beta-oxidation than DHA. Furthermore, radiolabeled palmitoleic acid, a fatty acid that can be synthesized de novo, was detected in brain phospholipids from (14)C-EPA but not from (14)C-DHA-perfused mice suggesting that beta-oxidation products of EPA were recycled into endogenous fatty acid biosynthetic pathways. These findings suggest that low levels of EPA in brain phospholipids compared to DHA may be the result of its rapid beta-oxidation upon uptake by the brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237271     DOI: 10.1016/j.plefa.2009.01.005

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  46 in total

1.  Docosahexaenoic Acid and Eicosapentaenoic Acid Did not Alter trans-10,cis-12 Conjugated Linoleic Acid Incorporation into Mice Brain and Eye Lipids.

Authors:  Madhuri Vemuri; Yuriko Adkins; Bruce E Mackey; Darshan S Kelley
Journal:  Lipids       Date:  2017-08-04       Impact factor: 1.880

2.  Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet.

Authors:  Miki Igarashi; Lisa Chang; Kaizong Ma; Stanley I Rapoport
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-09-16       Impact factor: 4.006

3.  Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

Authors:  M Elizabeth Sublette; Steven P Ellis; Amy L Geant; J John Mann
Journal:  J Clin Psychiatry       Date:  2011-09-06       Impact factor: 4.384

Review 4.  Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings.

Authors:  Robert K McNamara; Ruth H Asch; Diana M Lindquist; Robert Krikorian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-05-09       Impact factor: 4.006

Review 5.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

Review 6.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

7.  Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  P A Dacks; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2013-03       Impact factor: 4.075

8.  Delayed Docosahexaenoic Acid Treatment Combined with Dietary Supplementation of Omega-3 Fatty Acids Promotes Long-Term Neurovascular Restoration After Ischemic Stroke.

Authors:  Hongjian Pu; Xiaoyan Jiang; Xiaoming Hu; Jinchao Xia; Dandan Hong; Wenting Zhang; Yanqin Gao; Jun Chen; Yejie Shi
Journal:  Transl Stroke Res       Date:  2016-08-27       Impact factor: 6.829

9.  Anti-inflammatory nutrition as a pharmacological approach to treat obesity.

Authors:  Barry Sears; Camillo Ricordi
Journal:  J Obes       Date:  2010-09-30

10.  Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.

Authors:  Jodianne T Wood; John S Williams; Lakshmipathi Pandarinathan; David R Janero; Carol J Lammi-Keefe; Alexandros Makriyannis
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.